Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology (Fall) > Drugs for Hypertension - Part 3 & 4 > Flashcards

Drugs for Hypertension - Part 3 & 4 Flashcards

1
Q

Describe Calcium Channel Blockers (CCBs) & when they are useful

A
  • Excellent first line single therapy in uncomplicated hypertension
  • Low incidence of side effects (but expensive)
  • Neutral metabolic profile (no effect on cholesterol and glucose)
  • Useful when beta-blockers are contraindicated
  • not contraindicated in asthma, COPD, or diabetes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are two classes that block L-type calcium channels?

A

– Vascular Acting (dihydropyridines): amlodipine, NIFEDIPINE
* greater affinity for vascular calcium channels

– Cardiac (non-dihydropyridines): VERAPAMIL, DILITIAZEM
* blocks calcium channels primarily in cardiac tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe Vascular Acting(dihydropyridines) which Block L-type calcium channels (Calcium Channel Blockers - CCBs)

A

AMLODIPINE, NIFEDIPINE
* greater affinity for vascular calcium channels (acting primarily through arterial system)
* relaxes blood vessels (arteries)
** reduce TPR WITHOUT apparent direct cardiac actions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When are Vascular Acting(dihydropyridines) which Block L-type calcium channels (Calcium Channel Blockers - CCBs) useful/used for?

A

– Useful for angina and hypertension treatments (chronic HTN)
– Used for hypertensive crisis
– Long acting medications are used for hypertension
– Also used to treat pulmonary hypertension
– NIFEDIPINE is safe to use for blood pressure lowering in pregnancy – diuretics may block nifedipine effects on BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe Cardiac (non-dihydropyridines) which Block L-type calcium channels (Calcium Channel Blockers - CCBs)

A

VERAPAMIL, DILTIAZEM
– Used to treat hypertension when there is a concern about heart rate regulation in atrial fibrillation or in patients with angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Verapamil:

A
  • blocks calcium channels mainly in cardiac tissue
  • Should not be combined with a beta-adrenergic receptor blocker because both drugs block AV node (therefore, decrease HR –> decrease CO even more than it is)
  • Contraindicated in heart failure

(a Cardiac (non-dihydropyridines) which Block L-type calcium channels (Calcium Channel Blockers - CCBs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diltiazem:

A
  • both vascular and cardiac effects
  • Used to treat angina and hypertension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are Calcium Channel Blockers Adverse Effects?

A
  • Adverse effects related to vasodilation: (get too much vasodilation & decrease BP)
  • especially:
  • increased mortality post-MI with short acting preparations of nifedipine
  • never decrease BP rapidly, only 20mmHg at a time
    ** Combination of beta-blockers with CCBs leads to hypotension
  • Amlodipine causes carries risk of edema
  • Combination with ACEi avoids edema
  • since verapamil reduces cardiac contractility it *can’t be used in heart failure
  • published concerns about increased risk of cancer and GI bleeding appear unsubstantiated in larger studies

(quite safe to treat HTN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are Common Side effects of Calcium Channel Blockers?

A
  • Constipation
  • Vertigo
  • Headache
  • Fatigue
  • Hypotension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are Metoprolol & Carvedilol?

A

B-Adrenergic Receptor Blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe B-Adrenergic Receptor Blockers

Metoprolol, Carvedilol

A
  • many many B-blockers but all ↓ blood pressure.
  • mechanism of BP reduction not really known.
    – obvious to think - decreased CO
    — but CO may return to normal over the long-term
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe B-Adrenergic Receptor Blockers

Carvedilol

A
  • blocks B- AND a-adrenergic receptors (non-selective)
  • a-adrenergic receptor blockade helps to relax (dilate) arteries
    – the heart does not have to work as hard to eject blood
    — decreases afterload
  • B-adrenergic receptor blockade slows the heart and decreases force of contraction (↓ BP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe B-Adrenergic Receptor Blockers

Metoprolol

A
  • similar benefits to carvedilol
  • selectively blocks B1-adrenergic receptors (↓ BP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How effective are B-Adrenergic Receptor Blockers?

A
  • effective (?) treatment but now controversy - not metabolically neutral
    – increased TG, reduced HDLs
    (may be why they’re)— increased incidence of type 2 diabetes
    – lower blood pressure but no decrease in cardiovascular mortality (or overall mortality)?
    (ACEi lower CV mortality, so are better, BB have no effect on CV mortality)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When are B-Adrenergic Receptor Blockers not effective/effective?

A

Not recommended as single therapy in uncomplicated hypertension

  • effective in other situations (and therefore used)
  • preventing 2nd myocardial infarction (major)
  • improvement of heartf ailure(major)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are side effects of B-Adrenergic Receptor Blockers?

A
  • Hypotension (may potentially cause large drops in BP)
  • Bradycardia (blocks B1-adrenergic receptors on the heart - normally not a problem to have a low HR)
  • Fatigue (CNS effect)
  • Insomnia (CNS effect)
  • Sexual Dysfunction (decreased libido, may cause impotence - compliance issues?)
    – decrease compliance with taking BB (don’t want to just stop taking b/c will get rebound HTN & will be higher than before taking, therefore take them off slowly)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When should you avoid/take B-Adrenergic Receptor Blockers?

A
  • avoid sudden withdrawal
  • good to block reflex activation of the heart by the SNS
  • avoid where β-adrenergic receptor activity needed:
  • asthma, COPD, peripheral vascular disease, insulin dependent diabetes, physically active (?)
  • good if certain other diseases present (treats both):
  • glaucoma, certain arrhythmia, myocardial infarction, angina
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is an example of an alpha1-Adrenergic Receptor Antagonist? Describe it

A

Prazosin
- not effective as a single agent for chronic BP lowering
- vasodilates arteries and veins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the problems with alpha1-Adrenergic Receptor Antagonist in particular Prazosin?

A
  • first dose effect: initial large ↓ BP
  • postural hypotension
    – Patients should not stand up too quickly due to poor baroreflex
  • fluid retention with long-term treatment due to Na+ retention
    – give with diuretic (to try prevent electrolyte imbalances & fluid retension)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is an example of an alpha2-Adrenergic Receptor Agonist? Describe it

A

Clonidine
- acts on central vasomotor centres
- decreases SNA from the CNS
- net effect is to reduce peripheral vascular resistance - autonomic system remains intact
- given as two unequal doses
*– high dose at night: sedation (b/c makes you feel tired & than lower dose during day - b/c acting on CNS)
- typically used when patient is resistant to the use of other BP lowering medications (add on)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the problems with alpha2-Adrenergic Receptor Agonist in particular Clonidine?

A
  • rebound hypertension upon rapid cessation of drug (risk of not taking their medication)
  • dry mouth, sedation and hypotension potential adverse effects
  • not recommended to be used in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are Vasodilators NOT used for?

A

Not used for chronic blood pressure lowering (more for hospital setting - therefore less commonly used)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are 2 examples of Vasodilators?

A
  1. Hydralazine
  2. Sodium nitroprusside
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Describe Hydralazine

A

a Vasodilator
- relaxes vascular smooth muscle cells of resistance arterioles
- use in combination with a -blocker and diuretic
– stimulates SNA so may increase heart rate
– increases plasma renin so results in fluid retention (why a diuretic is also used)
*- used in pregnancy (gestational hypertension)
- safe for mother and infant and effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the problems with Hydralazine (a vasodilator)?

A
  • risk of lupus-like syndrome with long-term treatment (inflammatory disease)
  • headache, hypotension, tachycardia, angina
  • may potentiate anti-hypertensive effects of ACEi, CCBs and diuretics (good or bad thing - could lower BP too much)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Describe Sodium nitroprusside

A

a Vasodilator
- both venous and arteriolar dilator
- infused intravenously
– breaks down to produce nitric oxide (NO) (a potent vasodilating molecule)
- used for acute hypertensive crisis (emergency)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are problems with Sodium nitroprusside (vasodilator)?

A
  • potential for cyanide toxicity (b/c highly reactive NO molecule so potential for cyanide toxicity)
  • should not use in pregnancy
  • risk of hypotension, low heart rate
  • do not use in patients with kidney disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Drug therapy for specific disease mechanisms of hypertension

What is used for Volume overload?

A

– Thiazide; loop diuretic; aldosterone antagonist

(underline edema)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Drug therapy for specific disease mechanisms of hypertension

What is used for Sympathetic overactivity?

A

– B-blocker (use to counteract reflex tachycardia from vasodilators or in heart failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Drug therapy for specific disease mechanisms of hypertension

What is used for Increased vascular resistance?

A

– ACE inhibitor or ARB (use in heart failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Drug therapy for specific disease mechanisms of hypertension

What is used for Smooth-muscle contraction?

A

– Dihydropyridine CCBs; B-blocker; hydralazine (vasodilator)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

How often should patients with hypertension be seen?

If they have Stable, well-controlled hypertension?

A

Recheck at 6- to 12-month intervals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

How often should patients with hypertension be seen?

If their Blood pressure 140/90 to 159/99mmHg?

A

Recheck at 2 months intervals (stage 1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

How often should patients with hypertension be seen?

If their Blood pressure ≥160/100mmHg?

A

Recheck at ≤1 month intervals (stage 2)

35
Q

After adjusting medications:

A

allow 2-4 weeks for blood pressure to stabilize

36
Q

Lab testing:

A

intervals depend on number and type of medications and medical comorbidity (electrolyte imbalances should be checked)

37
Q

Pulmonary Arterial Hypertension

What is Essential hypertension?

A

increase in blood pressure through WHOLE body

38
Q

Pulmonary Arterial Hypertension

What is Pulmonary hypertension?

A

hypertension LIMITED to the pulmonary vasculature

39
Q

What is the incidence of Pulmonary Arterial Hypertension?

A
  • In the US ~1000 new cases each year
  • Women more affected than men
  • Onset typically between 20 and 60 years of age (younger than essential HTN)
  • Mortality is 32%, 52% and 66% at 1, 3, 5yr diagnosis (*mortality rates are higher)
40
Q

What are the risk factors for Pulmonary Arterial Hypertension?

A
  • Overweight
  • Family History of PAH (genetic component)
  • Living at High Altitude
  • Sleep apnea
  • Drug Abuse
  • HIV infection

(but not much known)

41
Q

What are the symptoms for Pulmonary Arterial Hypertension?

A

*onset is typically gradual so symptoms may not be apparent until disease is advanced (therefore diagnosis can be late –> why mortality rates are high)
* Shortness of breath
- Initially only during exercise
- Later also at rest
* Fatigue
* Dizziness
* Chest pressure/pain
* Edema in ankles/legs
* Bluish colour of lips/skin
* Cardiac palpitations

42
Q

Symptoms of Pulmonary Arterial Hypertension

A
  • Tiredness, dizziness or fainting
  • Swelling of the abdomen
  • Swelling of the legs & ankles
  • SOB during normal activity, chest pain, fast heartbeat
  • Blue tint to lips or skin
43
Q

What are the complications of Pulmonary Arterial Hypertension?

A
  • Right ventricular hypertrophy/heart failure
  • Blood clots (in pulmonary circulation)
  • Cardiac arrhythmias
  • Blood in the lungs
44
Q

What is Pulmonary hypertension mainly due to?

A

mainly due to the tiny blood vessels in the lung becoming thickened, narrowed or blocked thereby increasing pulmonary vascular resistance
* Cells that line the pulmonary arteries become stiff and thick as well as inflamed and tight

45
Q

What are the many potential causes of the increased resistance seen in Pulmonary hypertension?

A
  • Congenital heart disease
  • Heart failure
  • Emphysema
  • Blood clots (pulmonary embolism)
  • Lung tumours
  • Drugs (e.g. methamphetamines)
  • Unknown causes (don’t notice until more adv. stages)
46
Q

What does the increased resistance to flow to the right ventricle, lung capillaries, & left atria cause in pulmonary hypertension?

A
  • increased resistance to flow through lungs
  • right ventricle must work harder – enlarges
  • may not be able to pump effectively
  • Increased preload on right side of heart
    – venous pressure increases - edema (in peripheral circulation)
47
Q

In healthy pulmonary blood vessels constriction and relaxation are balanced. How?

A
  • constrictors - endothelin
  • relaxers - nitric oxide (NO), prostacyclin
48
Q

In pulmonary hypertension there is an imbalance. How?

A
  • too much constriction - endothelin (overactive)
  • not enough relaxation - NO and prostacyclin
49
Q

What does Nitric oxide do on the system?

A
  • Vasorelaxation
  • Anti-proliferation
  • Anti-fibrosis
  • Anti-inflammation
  • Anti-thrombosis
50
Q

What does Endothelian-1 do on the system?

A
  • Vasoconstriction
  • Proliferation
  • Fibrosis
  • Inflammation
  • Release of vasodilators & vasoconstrictors
  • Endothelial clearance
51
Q

What does Prostacyclin do on the system?

A
  • Vasorelaxation
  • Anti-profileration
  • Anti-fibrosis
  • Anti-inflammation
  • Anti-thrombosis
52
Q

What are Pulmonary Arterial Hypertension Treatments?

A

Calcium channel blockers - NIFEDIPINE (long acting)
- arterial vessel relaxation
- absence of randomized trials
- some evidence for prolonged survival, function improvement
- evidence of effectiveness in only 5% of patients that are vasoreactive

Endothelin receptor antagonist - BOSENTAN

Prostacyclin
derivative - EPOPROSTENOL

Activator of soluble guanylate cyclase - SILDENAFIL

53
Q

What is the mechanism for Bosentan which is a Endothelin Receptor Antagonists for treatment of Pulmonary Arterial Hypertension?

A

Mechanism: antagonist of both Endothelin Receptors (use it earlier on)
* ET-A and ET-B
* Used to treat moderate pulmonary arterial hypertension
* decreases endothelin-mediated arterial constriction
* improves symptoms, six minute walk test, and survival (won’t feel fatigue)

54
Q

What is the adverse effects of Bosentan which is a Endothelin Receptor Antagonists for treatment of Pulmonary Arterial Hypertension?

A
  • hepatotoxicity a major problem
    ** Liver damage due to adverse drug interaction in patients prescribed
    glyburide (glucose-lowering) medication
  • may cause peripheral edema, nasal congestion
  • Causes birth defects in pregnant women
55
Q

What is the mechanism for Epoprostenol which is a Prostacyclin Derivatives for treatment of Pulmonary Arterial Hypertension?

A

Mechanism: activates a G-protein coupled Prostacyclin Receptor
* Synthetic prostacyclin
* Raises cellular cAMP levels and activated protein kinase A
* Net effect leads to arterial smooth muscle relaxation and vasodilation
* Considered most effective treatment for pulmonary arterial
hypertension
* improves exercise performance and survival

56
Q

What are the problems with Epoprostenol which is a Prostacyclin Derivatives for treatment of Pulmonary Arterial Hypertension?

A

prostacyclines are unstable (half-life 3-5min)
* must be continuously infused intravenously - nuisance

(effective but has shorter half-life)

57
Q

What are the adverse effects of Epoprostenol which is a Prostacyclin Derivatives for treatment of Pulmonary Arterial Hypertension?

A
  • Flushing
  • Headaches
  • hypotension
58
Q

What is the mechanism of Sildenafil which is an Inhibitor of soluble guanylate cyclase?

A

Mechanism: inhibits cGMP phosphodiesterase 5 (PDE5)
* prolongs effects of nitric oxide - prevents cGMP breakdown
* phosphodiesterase type 5 inhibitors increase arterial relaxation
* improved exercise performance
* not clear if it alters survival

(Viagra)

59
Q

What are the adverse effects of Sildenafil which is an Inhibitor of soluble guanylate cyclase?

A
  • Flushing
  • Headaches
  • Nausea
  • Diarrhea
    ** Should not be used with other medications containing nitric oxide
    donors
60
Q

How can you manage hypertension in the elderly (over 65)?

A
  • Aging reduces vascular compliance due to stiffening of the arteries that raises TPR and BP
  • Aging reduces the efficiency of sodium excretion resulting in increased blood volume and BP
  • BP goal: SBP< 150mmHg DBP< 90mmHg
  • BP should be lowered gradually to avoid complications
  • Start with low dose thiazide diuretic
  • Add on ACEi (decrease mortality) or CCB
  • B-blockers used if other CV conditions apparent in elderly patient (ex: heart failure)
61
Q

Managing Hypertension at Different Ages (No Diabetes or CKD)

Adult with hypertension aged 18-60years

A

BP goal < 140/90mmHg

  1. Implement lifestyle interventions
  2. ACEi (or ARB) monotherapy
  3. Maximize first medication before adding second
62
Q

Managing Hypertension at Different Ages (No Diabetes or CKD)

Adult with hypertension aged > 60years

A

BP goal < 150/90mmHg

  1. Salt Restriction
  2. Low Dose Thiazide Diuretic
  3. add on ACEi (or ARB) or CCB then B-blocker
63
Q

How can you manage hypertension in diabetes?

A
  • Insulin has vasodilatory properties
  • Insulin stimulates SNA without raising BP
  • Insulin resistance (as in T2D) hyperinsulinemia raises BP via SNA and insulin resistance negates the vasodilatory properties of insulin
  • BP goal: SBP< 130mmHg DBP< 90mmHg (not as aggressive in the elderly)
    ** Aggressive management of weight/salt intake recommended
  • ACEi are first line prescription then add on a diuretic
  • Beta-blockers not recommended due to metabolic effects (esp. as 1st line)
  • Dihydropyridine CCBs associated with higher risk of heart failure in diabetic patients
    ** Not uncommon for these patients to need 3 or more medications to achieve BP goals
64
Q

Managing Hypertension in Diabetic Patients (No CKD)

Adult with hypertension aged 18-60years

A

BP goal < 130/80mmHg

  1. Weight loss/salt restriction
  2. ACEi or diuretic monotherapy
  3. Maximize first medication before adding second (dihydropyridine CCB)

Combination therapy with additional classes of medications likely needed to achieve BP goal

65
Q

Managing Hypertension in Diabetic Patients (No CKD)

Adult with hypertension aged > 60years

A

BP goal < 140/90mmHg

  1. Weight loss/salt restriction
  2. ACEi or diuretic monotherapy
  3. Maximize first medication before adding second (dihydropyridine CCB)

Combination therapy with additional classes of medications likely needed to achieve BP goal

66
Q

How can you manage hypertension in Chronic Kidney Disease?

A

** Decline in kidney function associated with elevated BP
* Sustained high BP hastens reduced kidney function
* Impaired salt excretion in CKD raises BP via increased blood volume…salt intake worsens conditions
* BP goal: SBP< 120mmHg DBP< 80mmHg
* Salt restriction recommended….enhances effects of anti- hypertensive agents
** ACEi (or ARB) are first line prescription then add on a diuretic
* Thiazide diuretic recommended for most patients but use loop diuretic in combination in patients with advanced CKD (when disease progresses & kidney function decreases)
* Not uncommon for these patients to need 3 or more medications to achieve BP goals

67
Q

Managing Hypertension in CKD (no diabetes)

low proteinuria

A

BP goal < 120/80mmHg

  1. Salt restriction
    Monitor K levels
  2. ACEi monotherapy
  3. Add on Thiazide Diuretic

Combination therapy with additional classes of medications likely needed to achieve BP goal

68
Q

Managing Hypertension in CKD (no diabetes)

with proteinuria > 500mg/24h

A

BP goal < 140/90mmHg

  1. Salt restriction
    Monitor K levels
  2. ACEi/ARB mono or combination therapy
  3. Add on Thiazide Or Loop Diuretic

Combination therapy with additional classes of medications likely needed to achieve BP goal

69
Q

How do you manage hypertension in post-Myocardial Infarction?

A
  • Use sodium nitroprusside in patients presenting with acute myocardial infarction and severe hypertension
  • Long-term treatment is usually aimed at relieving symptoms, protecting ischemic tissue and preventing another CV event
  • In longer term BP goal: SBP< 160mmHg DBP< 110mmHg
    ** ACEi are first line prescription (or ARB if not tolerated) - b/c most effective in preventing mortality
  • Titrate the addition of a Beta-blocker to reduce SNA and strain on heart (benefit of 2nd MI)
70
Q

Managing Hypertension Following Myocardial Infarction

Acute and Severe Hypertension

A

BP goal<160/110mmHg

Gradually reduce BP over 24-48h

Sodium nitroprusside

71
Q

Managing Hypertension Following Myocardial Infarction

Chronic

A

BP goal<160/110mmHg

ACEi (or ARB) and beta-blocker therapy

Add on Cardiac Acting CCB (Diltiazem) (so they don’t get a 2nd MI)

72
Q

How do you manage hypertension in Pregnancy?

A
  • Reducing gestational hypertension is important to reduce maternal, fetal and infant complications, preterm birth, low birth weight and pregnancy loss
  • BP goal: SBP< 140mmHg DBP< 90mmHg
  • Nifedipine or beta-blockers (metoprolol) are first-line treatments
  • Hydralazine and thiazide diuretics are second-line medications
    ** ACEi and ARBs should NOT be used since they cause acute kidney damage to the fetus (1 situation where they aren’t safe)
73
Q

When should ACEi and ARBs not be used?

A

ACEi and ARBs should not be used since they cause acute kidney damage to the fetus

74
Q

Explain how you would manage hypertension in Pregnancy?

A

BP < 140/90mmHg
No: Normal BP Reassess at next visit
Yes: BP >160/110mmHg –> BP >160/110mmHg
Yes: Severe Hypertension
NIFEDIPINE
No: Beta-blocker (METOPROLOL) therapy Maternal/placental/fetal assessments –> DBP > 90mmHg
No: Continue Maternal/placental/fetal assessments
Yes: Increase dose of beta blocker or add on a diuretic (HYDROCHLOROTHIAZIDE)

75
Q

What is Resistance Hypertension?

A

** Blood pressure that remains above goal despite use of 3 antihypertensive medications from 3 different classes at the same time
* Cross sectional analyses suggest that anywhere from 25-50% of patients have BP controlled <130/85mmHg
* Presumably prognosis for CV events is poor

76
Q

What are the risk factors for resistance hypertension?

A

– Age>75years
– Obesity and Diabetes
– Excessive dietary salt ingestion (can reduce medication effectiveness)
– KidneyDisease
– Female Sex (high rate of undiagnosed of HTN)

77
Q

What are the drug-related causes of Resistance Hypertension?

A

– Alcohol

– Non-narcotic analgesics
* NSAIDs
* COX-2 inhibitors

– SympatheticAgents
* Decongestants
* Diet pills
* cocaine

– Oral Contraceptives

– Cyclosporine

(interact with lower BP medications)

78
Q

What are the Secondary causes of Resistance Hypertension?

A

– Obstructive sleep apnea
– Primary aldosteroidism
– Renal parenchymal disease
– Renal artery stenosis
– Uncommon:
* Cushings syndrome
* Hyperparathyroidism

(undiagnosed & contribute to HTN)

79
Q

When blood pressure is poorly controlled, how should clinicians decide among increasing dose, adding an additional agent, or switching to another drug class?

A
  • Consider ambulatory blood pressure monitoring
  • Ask about co-medication with blood pressure- increasing drugs
  • Ask about excessive alcohol or salt intake
  • Reconsider secondary causes of hypertension (maybe dev. diabetes etc.)
  • Evaluate medication adherence (not taking it, could be expensive)
  • Treat uncontrolled hypertension: use several drugs, each targeting different disease mechanism (that are underlying cause of HTN)
80
Q

When should referral to a hypertension specialist be considered?

A

➢Drug-resistant hypertension uncontrolled with ≥3 drugs

➢Uncertainty about how to evaluate or manage suspected secondary hypertension

➢Need for assistance assessing target organ damage

81
Q

Describe the flow chart of Resistance Hypertension?

A
  1. Confirm Treatment Resistance
    - Elevated BP in patient prescribed 3 or more medications at optimal doses
    Yes?
  2. Exclude Pseudoresistance
    - Obtain home or ambulatory BP measurements Is patient taking their medications?
    Yes?
  3. Reverse Contributing
    - Lifestyle Factors
    Physical inactivity, obesity, high salt intake, excessive alcohol consumption
    Yes?
  4. Discontinue Interfering Substances
    - NSAIDs, diet pills, decongestants, oral contracentives, other stimulants
    Yes?
  5. Screen for Secondary Causes
    - Sleep apnea, aldosteronism, pheochrmocytosis, chronic kidney disease, renal artery stenosis, Cushing’s syndrome, aortic coarction
    If YES refer to specialist
    No?
  6. Pharmacological Treatment
    - Maximize diuretic therapy
    Use loop diuretics in CKD patients Combine medications with different mechanisms of action
    (e.g. ACEi/diuretic/CCB)
    No?
  7. Refer to Specialist
    - If BP remains uncontrolled after 6 months of treatment refer to a hypertension specialist
82
Q

What is the management of confirmed Resistance Hypertension?

A

➢Add a fourth medication

➢Greatest BP lowering achieved with addition of
spironolactone (acting on aldosterone system –> diff. mech as others)

➢ then use alpha- or beta-adrenergic receptor antagonists

➢then use clonidine

➢Add additional medications from different classes
not already used

83
Q

CASE STUDY

A

Pharmacology (Fall) (28 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions